Kaléo has announced the appointment of a chief commercial officer as well as the formation of a government sector business unit.

Alfred Tenuto has been named CCO, a role in which he will oversee growth of the company’s pharmaceutical business. Mark Herzog joins the company as VP and will lead the organization’s newly formed government sector business unit.

The new unit will focus on domestic and international expansion of Kaléo’s Rapid Opioid Countermeasure System.